Leukemia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Leukemia stocks.

Symbol Grade Name Weight

View all Leukemia related ETFs...

Compare ETFs

    Recent Signals

    Date Stock Signal Type
    2021-05-17 HEMO NR7 Range Contraction
    2021-05-17 HEMO NR7-2 Range Contraction
    2021-05-17 HEMO Narrow Range Bar Range Contraction
    2021-05-17 HEMO Boomer Sell Setup Bearish Swing Setup
    2021-05-17 SAR New 52 Week Closing High Bullish
    2021-05-17 SAR New Uptrend Bullish
    2021-05-17 SAR Slingshot Bullish Bullish Swing Setup
    2021-05-17 SAR 20 DMA Support Bullish
    2021-05-17 SAR Expansion Breakout Bullish Swing Setup
    2021-05-17 SAR Expansion Pivot Buy Setup Bullish Swing Setup
    2021-05-17 SAR Pocket Pivot Bullish Swing Setup
    2021-05-17 SAR Reversal New Highs Setup Bullish Swing Setup
    2021-05-17 SAR 50 DMA Support Bullish
    2021-05-17 SAR Volume Surge Other
    2021-05-17 SAR Wide Range Bar Range Expansion

    Recent News for Leukemia Stocks

    Date Stock Title
    Related Industries: Drug Manufacturers - Major

    Leukemia, also spelled leukaemia, is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. Five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60% or even 90%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people worldwide and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three-quarters of leukemia cases in children being the acute lymphoblastic type. However, over 90% of all leukemias are diagnosed in adults, with CLL and AML being most common in adults. It occurs more commonly in the developed world.

    More about Leukemia
    Browse All Tags